4.4 Article

Comprehensive analysis of soluble RNAs in human embryo culture media and blastocoel fluid

Journal

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
Volume 37, Issue 9, Pages 2199-2209

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10815-020-01891-7

Keywords

miRNA; tiRNA; Biomarker; Culture medium; ART

Funding

  1. Vitrolife (Grant for the development of ART)
  2. Hjalmar Svensson Foundation
  3. Danish Council for Independent Research Medical Sciences
  4. Novo Nordisk

Ask authors/readers for more resources

Purpose miRNAs have been suggested as biomarkers of embryo viability; however, findings from preliminary studies are divergent. Furthermore, the presence of other types of small RNA molecules remains to be investigated. The purpose of this study was to perform a comprehensive analysis of small non-coding RNA levels in spent and unconditioned embryo culture media, along with miRNA levels in blastocoelic fluid samples from human embryos. Methods miRNAs in unconditioned culture medium from 3 different manufacturers, along with miRNA from day 5 conditioned culture medium, control medium, and corresponding blastocoel fluid from 10 human blastocysts were analyzed with array-based q-PCR analysis. Subsequently, deep sequencing of total and small RNA in day 5 spent culture medium from 5 human blastocysts and corresponding controls was performed. Results In spite of using state-of-the-art sensitive detection methods, no miRNAs were found to be reliably present in the spent culture medium or the blastocoel fluid.C(t)values were above the recommended limit for detection in the array-based analysis, a finding that was confirmed by deep sequencing. The majority of miRNAs identified by deep sequencing were expressed in all samples including control media and seem to originate from sources other than conditioned IVF media. Conclusions Our findings question the use of miRNAs as a reliable biomarker and highlight the need for a critical methodological approach in miRNA studies. Interestingly, tiRNA fragments appear to be overexpressed in conditioned IVF media samples and could potentially be a novel biomarker worthy of investigation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer

Doron Tolomeo, Debora Traversa, Santina Venuto, Karoline K. Ebbesen, Juan L. Garcia Rodriguez, Grazia Tamma, Marianna Ranieri, Giorgia Simonetti, Martina Ghetti, Matteo Paganelli, Grazia Visci, Arcangelo Liso, Klaas Kok, Lucia Anna Muscarella, Federico Pio Fabrizio, Maria Antonia Frassanito, Aurelia Lamanuzzi, Ilaria Saltarella, Antonio Giovanni Solimando, Alessandro Fatica, Zaira Ianniello, Rene Massimiliano Marsano, Antonio Palazzo, Amalia Azzariti, Vito Longo, Stefania Tommasi, Domenico Galetta, Annamaria Catino, Alfredo Zito, Tommaso Mazza, Alessandro Napoli, Giovanni Martinelli, Jorgen Kjems, Lasse Sommer Kristensen, Angelo Vacca, Clelia Tiziana Storlazzi

Summary: Small cell lung cancer (SCLC) is a heterogeneous disease characterized by distinct molecular subtypes. The amplification of MYC oncogene in SCLC is associated with different histological classes. Circular (circRNA) and chimeric RNAs derived from the co-amplified PVT1 gene were found to have a functional role in SCLC, promoting cell growth and preventing apoptosis. These PVT1 transcripts also showed a connection between MYC and YAP1/POU2F3, contributing to the transcriptional landscape of MYC-amplified tumors. These findings suggest that circular and chimeric PVT1 transcripts could serve as novel biomarkers for MYC-amplified SCLC.

GENES CHROMOSOMES & CANCER (2023)

Article Oncology

Circulating immune response proteins predict the outcome following disease progression of osimertinib treated epidermal growth factor receptor-positive non-small-cell lung cancer patients

Christoffer T. Maansson, Sofie Helstrup, Eva B. F. Ebert, Peter Meldgaard, Boe S. Sorensen

Summary: This study discovers novel circulating biomarkers that can predict the overall survival after progressive disease (PD) on osimertinib treatment in non-small-cell lung cancer patients with EGFR mutations. The altered expression of immune system-related proteins at PD provides insight into osimertinib resistance.

TRANSLATIONAL LUNG CANCER RESEARCH (2023)

Article Chemistry, Multidisciplinary

Specific Detection of Proteins by a Nanobody- Functionalized Nanopore Sensor

Xialin Zhang, Nicole Stephanie Galenkamp, Nieck Jordy van der Heide, Giovanni Maglia, Jorgen Kjems, Julian Moreno

Summary: Nanopores functionalized with different nanobodies show great potential for stochastic sensing of proteins. They can detect Spike protein, HER2 receptor, and muPA protein through reversible blockade events or larger blockage signals, enabling the clinical detection of protein biomarkers.

ACS NANO (2023)

Article Biochemistry & Molecular Biology

Biased activation of the receptor tyrosine kinase HER2

Claudia Catapano, Johanna V. Rahm, Marjan Omer, Laura Teodori, Jorgen Kjems, Marina S. Dietz, Mike Heilemann

Summary: HER2 belongs to the ErbB sub-family of receptor tyrosine kinases and is activated through heterodimerization with other ErbB receptors. This study found that HER2 is strongly activated by EGFR-targeting ligands EGF and TGFa, with a distinguishable temporal fingerprint. HER4-targeting ligands EREG and NRG beta 1 showed weaker activation of HER2, with a preference for EREG and a delayed response to NRG beta 1.

CELLULAR AND MOLECULAR LIFE SCIENCES (2023)

Article Immunology

The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation

Dirk Reinhold, Vadim Farztdinov, Yan Yan, Christian Meisel, Henrik Sadlowski, Joachim Kuehn, Frank H. Perschel, Matthias Endres, Emrah Duezel, Stefan Vielhaber, Karina Guttek, Alexander Goihl, Morten Veno, Bianca Teegen, Winfried Stoecker, Paula Stubbemann, Florian Kurth, Leif E. Sander, Markus Ralser, Carolin Otto, Simon Streit, Sven Jarius, Klemens Ruprecht, Helena Radbruch, Jorgen Kjems, Michael Muelleder, Frank Heppner, Peter Koertvelyessy

Summary: Patients with COVID-19 may experience various neurological symptoms, but the role of the central nervous system (CNS) in COVID-19 is still unclear. The inflammatory response in the cerebrospinal fluid (CSF) of COVID-19 patients was studied, and it was found that there were attenuated inflammatory changes compared to patients with herpes simplex virus encephalitis (HSVE). The inflammatory mediators in the CSF of COVID-19 patients were likely derived from the systemic circulation rather than produced within the CNS. Further investigation is needed to understand the relevance of blood-derived mediators of inflammation in the CSF for neurological COVID-19 and post-COVID-19 symptoms.

JOURNAL OF NEUROINFLAMMATION (2023)

Article Oncology

Impact of U2AF1 mutations on circular RNA expression in myelodysplastic neoplasms

Eileen Wedge, Ulvi Ahmadov, Thomas B. Hansen, Zongliang Gao, Morten Tulstrup, Christophe Come, Sridhar Nonavinkere Srivatsan, Tanzir Ahmed, Jakob S. Jespersen, Balthasar C. Schlotmann, Claudia Schollkopf, Klas Raaschou-Jensen, Niels Odum, Jorgen Kjems, Rasmus O. Bak, Matthew J. Walter, Kirsten Gronbaek, Lasse S. Kristensen

Summary: Mutations in the U2AF1 gene are associated with a higher occurrence of myelodysplastic neoplasms (MDS) and a worse prognosis, but the exact molecular mechanisms are not fully understood. This study found that U2AF1 mutations may impact circRNA production, leading to increased cancer development. Increased circRNA expression levels were observed in cells and patient samples with U2AF1 mutations, suggesting a potential role of circRNA as a biomarker and therapeutic target in MDS.

LEUKEMIA (2023)

Article Oncology

Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel

Judit Kisistok, Ditte Sigaard Christensen, Mads Heilskov Rasmussen, Lone Duval, Ninna Aggerholm-Pedersen, Adam Andrzej Luczak, Boe Sandahl Sorensen, Martin Roelsgaard Jakobsen, Trine Heide Oellegaard, Nicolai Juul Birkbak

Summary: Immunotherapy has dramatically improved the treatment outcomes for metastatic melanoma patients, but it also brings immune-related adverse events. Identifying nonresponding patients early is crucial, and this study explores the use of circulating tumor DNA (ctDNA) analysis as a minimally invasive tool. In a cohort of 24 melanoma patients, the presence of ctDNA was associated with poor prognosis, suggesting its potential to be used in clinical practice.

MELANOMA RESEARCH (2023)

Article Neurosciences

A Circular RNA Expressed from the FAT3 Locus Regulates Neural Development

Sabine Seeler, Maria Schertz Andersen, Tamas Sztanka-Toth, Mateja Rybiczka-Tesulov, Marleen H. van den Munkhof, Chi-Chih Chang, Muyesier Maimaitili, Morten Trillingsgaard Veno, Thomas Birkballe Hansen, R. Jeroen Pasterkamp, Agnieszka Rybak-Wolf, Mark Denham, Nikolaus Rajewsky, Lasse Sommer Kristensen, Jorgen Kjems

Summary: Using RNA-sequencing, this study reveals that circRNA levels significantly increase during the differentiation of human embryonic stem cells into neural progenitor cells. Knockdown of circFAT3 leads to transcriptional alterations and loss of specific cell types in cerebral organoids. Depletion of circFAT3 in mouse prefrontal cortex affects the positioning of electroporated cells. These findings highlight the important role of circFAT3 in neural development.

MOLECULAR NEUROBIOLOGY (2023)

Article Oncology

Cell-free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patients

Christoffer Trier Maansson, Peter Meldgaard, Magnus Stougaard, Anders Lade Nielsen, Boe Sandahl Sorensen

Summary: Cell-free chromatin immunoprecipitation (cfChIP) of H3K36me3-modified nucleosomes in blood plasma can be used to determine tumor gene expression levels. In this study, cfChIP-seq was performed on blood plasma samples from lung cancer patients and healthy controls. The results showed increased enrichment of mutated alleles in plasma from patients with somatic cancer mutations, and concordant H3K36me3 cfChIP enrichment profiles in different lung cancer types. These findings demonstrate the utility of cfDNA in liquid biopsies for characterizing cancer and predicting disease progression.

MOLECULAR ONCOLOGY (2023)

Article Oncology

Examination of the Functional Relationship between PD-L1 DNA Methylation and mRNA Expression in Non-Small-Cell Lung Cancer

Trine V. Larsen, Nina Dybdal, Tina F. Daugaard, Johanne Lade-Keller, Lin Lin, Boe S. Sorensen, Anders L. Nielsen

Summary: This study investigates the role of PD-L1 DNA methylation in regulating and predicting PD-L1 expression in non-small-cell lung cancer (NSCLC) patients undergoing immunotherapy. The analysis of tumor biopsies and cell lines reveals that PD-L1 DNA methylation status influences its expression. However, the correlation between methylation and expression is weak in NSCLC tumor samples. This study emphasizes the importance of further research to improve the effectiveness of PD-1/PD-L1 immunotherapy in NSCLC.

CANCERS (2023)

Article Oncology

Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer

Simone Stensgaard, Astrid Thomsen, Sofie Helstrup, Peter Meldgaard, Boe S. Sorensen

Summary: In this study, the researchers investigated whether circulating tumor DNA (ctDNA) could predict response to pembrolizumab in patients with non-small cell lung cancer (NSCLC). The results showed that high blood tumor mutational burden (bTMB) was associated with longer progression-free survival (PFS) and overall survival (OS). Moreover, an increase in ctDNA levels after treatment initiation was significantly correlated with inferior survival.

TRANSLATIONAL LUNG CANCER RESEARCH (2023)

Article Engineering, Biomedical

Protein ligand and nanotopography separately drive the phenotype of mouse embryonic stem cells

Sadegh Ghorbani, Annette Christine Fuchtbauer, Andreas Mollebjerg, Pia Moller Martensen, Sara Hvidbjerg Laursen, David Christian Evar Kraft, Jorgen Kjems, Rikke Louise Meyer, Karim Rahimi, Morten Foss, Ernst-Martin Fuchtbauer, Duncan S. Sutherland

Summary: Biochemical and biomechanical signals in the niche environments regulate stem cell function. A study compared in vitro signals from LN-511 and/or topographic cues to maintain stemness in mESCs. The integration of LN-511 with nanotopography decreased colony growth but maintained stemness markers, suggesting the antagonistic effect of combining biochemical and topographic signals. Faster colony growth was observed at nanotopographies without LN-511, indicating improved ESC expansion.

BIOMATERIALS (2023)

Article Oncology

Spatial Profiling of Circular RNAs in Cancer Reveals High Expression in Muscle and Stromal Cells

Juan L. Garcia-Rodriguez, Ulrik Korsgaard, Ulvi Ahmadov, Morten T. Jarlstad Olesen, Kim-Gwendolyn Dietrich, Emma B. Hansen, Stine M. Vissing, Benedichte P. Ulhoi, Lars Dyrskjot, Karina D. Sorensen, Jorgen Kjems, Henrik Hager, Lasse S. Kristensen

Summary: The abundance of circRNAs varies systematically between subcompartments of solid tumors and adjacent tissues, suggesting that differentially expressed circRNAs may reflect differences in cell type composition. These findings highlight the limitations of bulk tissue analyses and emphasize the need for spatial analysis in cancer research.

CANCER RESEARCH (2023)

Article Oncology

Circulating cell-free HPV DNA is a strong marker for disease severity in cervical cancer

Sara Bonlokke, Torben Steiniche, Boe Sandahl Sorensen, Gitte-Bettina Nyvang, Jacob Christian Lindegaard, Jan Blaakaer, Jesper Bertelsen, Katrine Fuglsang, Mikael Lenz Strube, Suzan Lenz, Magnus Stougaard

Summary: This study demonstrates the association between circulating cell-free HPV DNA (ccfHPV) and disease severity in cervical cancer. HPV integration status is also correlated with viral load and survival. The findings suggest that ccfHPV presence may contribute to the identification of patients suitable for adjuvant oncological therapy.

MOLECULAR ONCOLOGY (2023)

Article Oncology

Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer

Simone Stensgaard, Astrid Thomsen, Sofie Helstrup, Peter Meldgaard, Boe S. Sorensen

Summary: This study investigated the predictive value of circulating tumor DNA (ctDNA) in response to pembrolizumab treatment for non-small cell lung cancer (NSCLC) patients. The study found that high blood tumor mutational burden (bTMB) was associated with longer progression-free survival and overall survival. Additionally, an increase in ctDNA levels after treatment initiation was significantly correlated with inferior survival.

TRANSLATIONAL LUNG CANCER RESEARCH (2023)

No Data Available